Cite
HARVARD Citation
Rubio‐Rivas, M. et al. (2021). Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis. Pharmacotherapy. 41 (11), pp. 884-906. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rubio‐Rivas, M. et al. (2021). Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis. Pharmacotherapy. 41 (11), pp. 884-906. [Online].